Heel Defender Orthotic Insoles selected for clinical trial
Defender Operations announced on Tuesday that its flagship product, Heel Defender Comfort Orthotic Insoles, has been selected for use in a clinical trial of a new treatment for Achilles Tendonitis.
The treatment entails the injection of a bioactive tissue matrix allograft to promote healing of chronic Achilles Tendonitis. A clinical trial is currently underway to investigate the therapeutic results of this treatment. Potentially, this therapy could help millions suffering from their painful and debilitating foot condition.
An important part of the clinical trial is the use of Heel Defender Comfort Orthotic Insoles by patients post-treatment to offload the pressure on their heel when standing or walking.
“Heel Defender orthotics are simply the best solution available on the market for decreasing pressure on the painful heel,” said Jason Hanft, a Miami foot and ankle surgeon with more than 30 years of experience. Hanft invented Heel Defender after his own heel was crushed in an accident and he could not find an effective orthotic to relieve his chronic foot pain. He developed Heel Defender to meet his own need and help others. The product is currently sold on Amazon.
No comments found